Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

Josje J. Otten; Hester E. Elzinga; Rik J. L. van der Lans; Wytske J. Fokkens; Sietze Reitsma; PolyREG Consortium

doi:10.1111/all.16496

Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

Josje J. Otten
, Hester E. Elzinga
, Rik J. L. van der Lans
, Wytske J. Fokkens
, Sietze Reitsma^*
, PolyREG Consortium

^*Corresponding author for this work

Amsterdam UMC - University of Amsterdam

Research output: Contribution to journal › Comment/Letter to the editor › Academic

41 Downloads (Pure)

Original language	English
Pages (from-to)	1166-1168
Number of pages	3
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	80
Issue number	4
Early online date	2025
DOIs	https://doi.org/10.1111/all.16496
Publication status	Published - Apr 2025

Keywords

chronic rhinosinusitis
control
dupilumab
nasal polyps
remission

Access to Document

10.1111/all.16496

Almost-half-of-the-dupilumab-treated-patients-with-severe-chronic-rhinosinusitis-with-nasal-polyps-achieve-remission-in-.pdfFinal published version, 166 KB

Cite this

@article{d005bea07bd74f9eadec796dfcad194e,

title = "Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year",

keywords = "chronic rhinosinusitis, control, dupilumab, nasal polyps, remission",

author = "Otten, \{Josje J.\} and Elzinga, \{Hester E.\} and \{van der Lans\}, \{Rik J. L.\} and Fokkens, \{Wytske J.\} and Sietze Reitsma and \{PolyREG Consortium\} and Cornet, \{M. E.\} and Rinia, \{A. B.\} and Kleiss, \{I. J.\} and I. Krebbers and Adriaensen, \{G. F. J. P. M.\} and Benoist, \{L. B. L.\} and Hoven, \{D. R.\} and Timmer, \{F. C. A.\}",

year = "2025",

month = apr,

doi = "10.1111/all.16496",

language = "English",

volume = "80",

pages = "1166--1168",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley Blackwell",

number = "4",

}

Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year. / Otten, Josje J.; Elzinga, Hester E.; van der Lans, Rik J. L. et al.
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 80, No. 4, 04.2025, p. 1166-1168.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

AU - Otten, Josje J.

AU - Elzinga, Hester E.

AU - van der Lans, Rik J. L.

AU - Fokkens, Wytske J.

AU - Reitsma, Sietze

AU - PolyREG Consortium

AU - Cornet, M. E.

AU - Rinia, A. B.

AU - Kleiss, I. J.

AU - Krebbers, I.

AU - Adriaensen, G. F. J. P. M.

AU - Benoist, L. B. L.

AU - Hoven, D. R.

AU - Timmer, F. C. A.

PY - 2025/4

Y1 - 2025/4

KW - chronic rhinosinusitis

KW - control

KW - dupilumab

KW - nasal polyps

KW - remission

UR - https://www.scopus.com/pages/publications/85217540428

U2 - 10.1111/all.16496

DO - 10.1111/all.16496

M3 - Comment/Letter to the editor

C2 - 39912310

SN - 0105-4538

VL - 80

SP - 1166

EP - 1168

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 4

ER -

Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

Keywords

Access to Document

Other files and links

Cite this